Pegcetacoplan – Complement C3 Inhibition for GA

Time: 11:45 am
day: Day One

Details:

  • Discuss different clinical presentations of GA patients
  • Review the role of complement C3 inhibition with pegcetacoplan in GA secondary to AMD
  • Provide an update from the Phase 3 pegcetacoplan clinical studies

Speakers: